mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.4 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.4 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.4 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |